Relmada Therapeutics, Inc. - Common Stock (RLMD)

Relmada Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for pain and related disorders

The company is dedicated to addressing unmet medical needs through its advanced therapeutic candidates, which aim to provide safe and effective alternatives to existing pain management options. By leveraging its expertise in neuroscience and pharmacology, Relmada Therapeutics is working towards advancing novel therapies that enhance the quality of life for patients suffering from chronic pain conditions and other neurological issues.